Hill-Rom Holdings Downgraded to “Neutral” at Zacks (HRC)
Hill-Rom Holdings (NYSE:HRC) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, American Banking News reports. They currently have a $46.90 price target on the stock. Zacks‘ price objective indicates a potential upside of 8.82% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Morgan Stanley downgraded shares of Hill-Rom Holdings from an “equal weight” rating to an “underweight” rating in a research note to investors on Monday, November 11th. They now have a $36.00 price target on the stock. They noted that the move was a valuation call. Analysts at Wells Fargo & Co. downgraded shares of Hill-Rom Holdings from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, October 25th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $39.63.
Shares of Hill-Rom Holdings (NYSE:HRC) traded up 1.48% on Wednesday, hitting $43.74. The stock had a trading volume of 191,430 shares. Hill-Rom Holdings has a 52-week low of $30.55 and a 52-week high of $43.82. The stock’s 50-day moving average is $41.2 and its 200-day moving average is $38.02. The company has a market cap of $2.553 billion and a price-to-earnings ratio of 24.77.
Hill-Rom Holdings, Inc is a manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.